Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis

Objective: This study analyses liver stiffness (LS) dynamics in people with HIV (PWH) and advanced liver fibrosis who achieved sustained virological response (SVR) and assess factors associated with LS normalization or progression, after long-term follow-up.Design:Prospective multicenter cohort stud...

ver descrição completa

Detalhes bibliográficos
Autores: Martín Carmona, Jésica, Corona Mata, Diana, Téllez, Francisco, Navarrete Lorite, Miguel Nicolás, Barroso, Isabel, Carlos Alados, Juan, Palacios Muñoz, Rosario, Santos, Ignacio de los, Vera Méndez, Francisco Jesús, Imaz, Arkaitz, Raffo Márquez, Miguel, Morano Vázquez, Aitana Carla, José Galindo, María, Belinchón, Olga, Serrano Fuentes, Miriam, López Zúñiga, Miguel Ángel, Galera Peñaranda, Carlos, Reus Bañuls, Sergio Javier, Pineda, Juan A., Macías, Juan, Corma Gómez, Anaïs, Gehep-011 Study Group
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2025
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositório:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:dnet:recercat____::27ee5fc2aad68c05eb87f90841149302
Acesso em linha:https://hdl.handle.net/2445/228761
Access Level:Acceso aberto
Palavra-chave:Infeccions per VIH
Hepatitis C
Malalties del fetge
HIV infections
Liver diseases
Descrição
Resumo:Objective: This study analyses liver stiffness (LS) dynamics in people with HIV (PWH) and advanced liver fibrosis who achieved sustained virological response (SVR) and assess factors associated with LS normalization or progression, after long-term follow-up.Design:Prospective multicenter cohort study. Methods: This study included individuals with HIV/HCV co-infection from the Spanish GEHEP-011 cohort, fulfilling: pretreatment LS >= 9.5 kPa; sustained virological response (SVR) with direct-acting antiviral regimen; available measurement of LS at SVR. Factors associated with LS normalization (achieving <= 7.2 kPa in two consecutive measurement) and progression (increase of >20% LS at the last measurement available) were analyzed. Results: A total of 678 patients were included. The median follow-up was 40 (17-71) months. The repeated measures ANOVA revealed a significant main effect of time on LS. Overall, 221 (32.6%) achieved normalization. Lower probability of normalization was associated with advanced liver disease [baseline LS: sHR = 0.26 (95% CI, 0.19-0.37), P < 0.001; liver decompensation before SVR: sHR = 0.22 (0.05-0.97), P < 0.001; baseline MELD score: sHR = 0.81 (0.69-0.94), P = 0.006]. LS progression occurred in 50 (7.4%). Progression was associated with higher baseline LS [sHR = 1.04 (1.01-1.07), P = 0.007], controlled attenuation parameter (CAP) [CAP >= 280 dB/m: sHR = 2.94 (1.16-7.44)] and older age [sHR 1.06 (1.00-1.13), per year, P = 0.04]. Conclusions: In PWH, LS significantly decreases after HCV cure in the long-term, achieving values of <= 7.2 kPa. In a substantial proportion of patients, LS remain stable or even increases. Older age and concomitant steatotic liver disease are associated with LS progression.

Registros relacionados